近日,Vytrus Biotech在美容及醫療領域取得突破,推出了一項基於植物外泌體的新技術。該技術可應用於皮膚及毛髮護理,並引入了一個名為Exosomic Peptides的創新概念。這項發展有望為生技醫療市場帶來顯著影響。
植物外泌體技術引領創新
Vytrus Biotech最近發表了一項名為植物外泌體的技術,引起業界廣泛關注。植物外泌體是從植物細胞中提取的微小顆粒,包含豐富的生物活性成分,如蛋白質、脂質及核酸。這些顆粒能有效運輸活性成分至皮膚及毛髮,更好地實現護理效果。
Vytrus的植物外泌體技術不僅提高了產品的功效,還強調其天然和無害的屬性,使其在日益注重健康與安全的市場中具備競爭優勢。
Exosomic Peptides:客製化的顆粒技術
除了植物外泌體技術外,Vytrus還介紹了一個名為Exosomic Peptides的概念。這是一種客製化的外泌體技術,能根據不同需求調整活性成分的組合,從而針對不同的護理需求提供精准的解決方案。例如,針對乾燥皮膚和受損頭髮的不同護理需求,可調整活性成分的比例和類型,以達到最佳的護理效果。
Exosomic Peptides所具備的靈活性和高效性,使其成為未來個人化護理產品的一個重要方向。
走向更廣泛的應用與前景
Vytrus Biotech通過這些創新的技術,展示了外泌體在美容和醫療領域中的巨大潛力。未來,植物外泌體及Exosomic Peptides技術有望應用於更多產品,如抗老化護膚品、修護性護髮產品,甚至可能拓展至醫療護理,如傷口癒合和抗炎治療。
Vytrus Biotech的這些技術突破,也預示著生技醫療領域可能出現更多基於植物外泌體的創新應用,為市場提供更多高效且安全的產品選擇。
結論
Vytrus Biotech的植物外泌體技術及Exosomic Peptides概念為生技醫療領域帶來了革命性的變革。這些技術不僅具有高效性和靈活性,更滿足了市場對天然、安全產品的需求。隨著這些技術的逐步推廣和應用,預計將會在護膚、護髮及醫療護理等多個領域取得豐碩成果。
參考資料
- https://www.fiercebiotech.com/biotech/mbx-files-ipo-seeking-cash-take-challenger-ascendis-phase-3
- https://www.cosmeticsandtoiletries.com/cosmetic-ingredients/actives/news/22912976/vytrus-biotech-vytrus-biotech-develops-plant-exosomes-presents-customizable-exosomic-peptides
- https://finance.yahoo.com/news/best-peptides-company-2024-announced-130000101.html
- https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.1030162/full
- https://www.prnewswire.com/news-releases/arthex-biotech-announces-oral-presentation-on-atx-01-at-the-oligonucleotide–peptide-therapeutics-tides-conference-2024-302121361.html
- https://www.energy.gov/science/bes/articles/nature-inspires-new-wave-biotechnology
- https://cosmeticsbusiness.com/vytrus-unveils-plant-exosomes-for-skin-and-hair
- https://www.onlymyhealth.com/what-are-the-best-peptide-companies-and-their-legit-sources-to-buy-from-1720429750
- https://www.isaaa.org/kc/cropbiotechupdate/article/default.asp?ID=20533
- https://www.fiercebiotech.com/biotech/novartis-pays-peptidream-180m-radiopharma-big-bang-continues
- https://www.miragenews.com/brazilian-team-unearths-new-biotech-peptides-in-1151713/
- https://www.outlookindia.com/hub4health/peptides-for-sale-6-best-places-companies-to-buy-online
- https://www.nature.com/articles/s41587-022-01566-x
- https://www.fiercebiotech.com/biotech/merck-co-signs-220m-macrocyclic-peptide-deal-after-hailing-next-wave-drug-discovery
- https://www.nature.com/articles/s41587-022-01567-w
- https://www.fiercebiotech.com/medtech/uws-baker-lab-researchers-make-ai-strides-drug-peptides
- https://www.nature.com/articles/s41587-022-01226-0
- https://www.fiercebiotech.com/biotech/genentech-sees-more-potential-peptides-signs-1b-biobucks-deal-peptidream
- https://www.pharmaceutical-technology.com/data-insights/innovators-peptide-pharmacophores-pharmaceutical/
- https://www.fiercepharma.com/pharma/lilly-merck-double-down-peptide-targeted-drug-delivery-betting-billions-biobucks-peptidream
- https://www.biospace.com/vilya-bursts-onto-seattle-biotech-scene-with-50m-series-a
- https://www.nature.com/articles/nrd.2018.125
- https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.1037147/full
- https://www.nature.com/articles/nbt.4150
- https://www.prnewswire.com/news-releases/genscript-expands-peptide-production-capabilities-to-include-neoantigen-peptides-and-apis-301895270.html
- https://www.prnewswire.com/news-releases/genscript-expands-peptide-and-oligonucleotide-production-facility-in-china-301828241.html
- https://www.everydayhealth.com/weight/desperate-for-ozempic-and-mounjaro-some-people-are-turning-to-diy-versions/
- https://www.nature.com/articles/nbt.3932
- https://agfundernews.com/why-invaio-sciences-acquired-peptyde-bio-peptides-represent-a-major-opportunity-for-biologicals
- https://european-biotechnology.com/latest-news/cordenpharma-invests-eur900m-in-peptide-patform-expansion/
- https://www.nature.com/articles/nbt.3267
- https://www.fiercebiotech.com/biotech/another-day-another-billion-dollar-deal-for-peptidream-time-alnylam
- https://cosmeticsbusiness.com/vytrus-will-present-its-exclusive-natural-plant-exosomes
Powered by GeneOnline AI